Merus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
CEOSven Ante Lundberg
CEOSven Ante Lundberg
Employees—
Employees—
HeadquartersUtrecht, Utrecht
HeadquartersUtrecht, Utrecht
Founded2003
Founded2003
Employees—
Employees—
MRUS Key Statistics
Market cap2.72B
Market cap2.72B
Price-Earnings ratio-15.03
Price-Earnings ratio-15.03
Dividend yield—
Dividend yield—
Average volume792.78K
Average volume792.78K
High today$47.86
High today$47.86
Low today$45.20
Low today$45.20
Open price$45.20
Open price$45.20
Volume761.26K
Volume761.26K
52 Week high$52.04
52 Week high$52.04
52 Week low$18.21
52 Week low$18.21
MRUS News
Yahoo Finance 5d
Merus Moves 7.1% Higher: Will This Strength Last? - Yahoo FinanceMerus N.V. (MRUS) shares soared 7.1% in the last trading session to close at $44.93. The move was backed by solid volume with far more shares changing hands tha...
Yahoo Finance 6d
Will Merus N.V. Report Negative Q1 Earnings? What You Should Know - Yahoo FinanceThe market expects Merus N.V. (MRUS) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024...
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%